Silo Pharma Announces filing of Patent for Treatment of Fibromyalgia

SPU-26 Pain Management Using Ketamine Composition Action supports planned IND package submission to FDA for SP-26 ENGLEWOOD CLIFFS, NJ, March 27, 2023 -- Silo Pharma, Inc.   , a... | March 27, 2023

Related Keywords

United States ,Eric Weisblum ,Silo Pharma Inc ,Nasdaq ,Management Using Ketamine ,Pain Management ,Chief Executive Officer ,Silo Pharma ,Looking Statements ,Nc Stock Exchange ,News ,Information ,Press Release ,Rain ,Management ,Sing ,Ketamine ,Composition ,Action ,Supports ,Planned ,End ,Package ,Submission ,O ,Fda ,Or ,Englewood ,Arch ,023 ,Ilo Silo Us82711p2011 ,